Related Experiment Videos
Pediatric genitourinary tumors.
Paul A Merguerian1, Barry Chang
1Division of Pediatric Urology, Children's Hospital Central California, Madera, California, USA. pmerguerian@valleychildrens.org
Current Opinion in Oncology
|May 1, 2002
Summary
This review covers 2001 advances in pediatric genitourinary tumors, focusing on Wilms tumor and rhabdomyosarcoma. Research highlights molecular markers for predicting outcomes and long-term treatment complications.
Area of Science:
- Pediatric oncology
- Genitourinary oncology
- Molecular biology
Background:
- Rapidly evolving understanding of cellular, molecular, and genetic processes in pediatric tumorigenesis.
- Accumulating data on long-term outcomes and complications of treatment modalities for childhood genitourinary tumors.
Purpose of the Study:
- To review the 2001 literature on pediatric genitourinary tumors, including Wilms tumor, other renal tumors, and rhabdomyosarcomas.
- To highlight advances in clinical evaluation, treatment, and understanding of molecular/genetic markers predicting outcome.
- To discuss long-term complications of treatment and surgical outcomes.
Main Methods:
- Literature review of the 2001 scientific publications on pediatric genitourinary tumors.
- Analysis of reports from the National Wilms' Tumor Study Group and the Intergroup Rhabdomyosarcoma Study Group.
- Focus on molecular biology findings related to outcome prediction.
Main Results:
- National Wilms' Tumor Study Group reported decreased surgical complications when procedures are performed by pediatric surgical specialists.
- Long-term treatment complications, such as short stature and leukemia, were discussed.
- Intergroup Rhabdomyosarcoma Study Group presented results for nonmetastatic disease, improved prognosis from Study IV, and goals for Study V (reducing chemotherapy and radiotherapy).
Conclusions:
- Continued progress in pediatric genitourinary tumor treatment and understanding of molecular markers is evident.
- Emphasis on specialized surgical care and ongoing research to minimize treatment complications and improve outcomes.
- Future research directions include reducing chemotherapy and radiotherapy intensity while maintaining efficacy.